Sleep disturbance is rarely framed as a seasonal phenomenon, yet population-scale prescription data may offer one of the most objective windows into how light exposure shapes human sleep biology across the calendar year. Understanding these rhythms matters because hypnotic and sedative medications carry real risks — dependency, cognitive side effects, fall risk in older adults — making any modifiable environmental driver clinically significant.
Analyzing retrospective primary-care prescription records stratified by month, year, and patient sex, this study found that sedative-hypnotic dispensing reliably peaked during winter and early spring months and fell to its lowest point between May and August. Crucially, increasing day length was significantly and independently associated with reduced prescription rates, suggesting a direct photoperiodic influence on population-level sleep quality. The gender stratification revealed a meaningful divergence: in men, the seasonal decline began earlier (February) and was more pronounced, with incidence rate ratios ranging from 0.88 to 0.95 across February through September. Women showed a narrower and later dip confined mainly to June through August (IRR 0.94–0.97), with a counterintuitive slight uptick in February. Daylight saving time transitions also produced detectable, if short-lived, disruptions in prescribing rates. During the COVID-19 pandemic, prescription volumes paradoxically decreased rather than increased.
This work sits within a growing body of chronobiology research implicating circadian and seasonal light cycles in mood, sleep architecture, and mental health outcomes. The gender gap is particularly intriguing — it may reflect differences in circadian entrainment sensitivity, hormonal modulation of sleep homeostasis, or differential social schedules. However, several important limitations temper interpretation: prescription data is a proxy for sleep disorders rather than a direct clinical measure, confounders such as seasonal affective disorder, alcohol use, and general practitioner prescribing habits are difficult to disentangle, and the retrospective design cannot establish causation. The paradoxical pandemic decline warrants its own dedicated investigation. Considered alongside light-therapy and chronotherapeutic literature, these findings add incremental but useful population-level evidence that seasonal daylight duration is a meaningful, underappreciated driver of sleep pharmacology demand.
